Changes in tryptophan metabolite levels in the pathogenesis of inflammatory bowel diseases
Bulletin of Russian State Medical University · 15.11.2026 · (6)
DOI: 10.24075/brsmu.2026.067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Russian State Medical University, online erschienen am 15.11.2026. Verfasst von VA Sorokin und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Inflammatory bowel diseases (IBD) are characterized by progressive damage to the intestinal wall and a relapsing course. The pathogenesis of IBD, including the role of microbial tryptophan metabolism, remains incompletely understood. This single-center, cross-sectional study aimed to compare fecal and serum concentrations of tryptophan-derived indole metabolites between patients with IBD and healthy controls. The study included 29 patients with acute IBD and 36 healthy volunteers. Stool and venous blood samples were analyzed by high-performance liquid chromatography coupled with tandem mass spectrometry. In feces, the indole concentration decreased to 3.851 vs. 287.12 nmol/g (p < 0.0001); indole-3-butyrate grew to 0.881 vs. 0.02 (p < 0.0001); indole-3-acetate increased to 23.202 vs. 8.962 (p = 0.0090). In serum, tryptamine concentrations decreased to 0.120 vs. 0.775 nmol/L (p < 0.0001); serotonin dropped to 528.86 vs. 721.592 (p = 0.0051); and indole-3-butyrate concentrations increased to 4.66 vs. 3.564 (p = 0.0166). Among men with IBD, serum tryptamine dropped to 0.117 vs. 0.612 nmol/L (p < 0.0001), while indole-3butyrate grew to 6.267 vs. 3.223 (p = 0.0004). Among women with IBD, tryptamine decreased to 0.115 vs. 0.805 nmol/L (p < 0.0001), and serotonin concentrations were 42% lower (p = 0.0065). In men with IBD, serum indole-3-butyrate concentrations were 1.8 times higher than in women with IBD. Thus, in the presence of IBD, both microbial and systemic tryptophan metabolism are altered. Reduced indole levels may reflect inhibited microbial tryptophanase activity, whereas increased concentrations of individual indoles may indicate a compensatory rearrangement of microbial tryptophan metabolism. Sex-related differences were observed in the serotonin and indole pathways, which may modulate tolerogenic immune regulation through the aryl hydrocarbon receptor (AHR) and thereby influence intestinal inflammation.
Zitieren
APA
Sorokin, V., Apollonova, S., Abdulkhakov, S., Shakirova, G., Odintsova, A., Abdulkhakov, R., Roumiantsev, S., & Shestopalov, A. (2026). Changes in tryptophan metabolite levels in the pathogenesis of inflammatory bowel diseases. Bulletin of Russian State Medical University. https://doi.org/10.24075/brsmu.2026.067
Vancouver
Sorokin V, Apollonova S, Abdulkhakov S, Shakirova G, Odintsova A, Abdulkhakov R, et al. Changes in tryptophan metabolite levels in the pathogenesis of inflammatory bowel diseases. Bulletin of Russian State Medical University. 2026. doi:10.24075/brsmu.2026.067
BibTeX
@article{Sorokin2026,
author = {Sorokin, VA and Apollonova, SA and Abdulkhakov, SR and Shakirova, GF and Odintsova, AKh and Abdulkhakov, RA and Roumiantsev, SA and Shestopalov, AV},
title = {Changes in tryptophan metabolite levels in the pathogenesis of inflammatory bowel diseases},
journal = {Bulletin of Russian State Medical University},
year = {2026},
number = {6},
doi = {10.24075/brsmu.2026.067}
}
EUVIMED